Search research articles
Contact Us
Filters
Showing results (41-50 of 168) with videos related to
Page
of 17
Sort By:
Pharmacoeconomics
|
September 25, 2007
Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US
Joseph A Ladapo, Peter J Neumann, Ron Keren, et al.
Archives of Pediatrics & Adolescent Medicine
|
September 3, 2008
Parental tolerance of false-positive newborn screening results
Lisa A Prosser, Joseph A Ladapo, Donna Rusinak, et al.
Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association
|
January 31, 2006
Predictors of hospital charges for children admitted with asthma
Ruchi S Gupta, Meenakshi Bewtra, Lisa A Prosser, et al.
Pharmacoeconomics
|
March 21, 2013
Using a discrete choice experiment to elicit time trade-off and willingness-to-pay amounts for influenza health-related quality of life at different ages
Lisa A Prosser, Katherine Payne, Donna Rusinak, et al.
Journal of Public Health Dentistry
|
April 1, 2018
Integrative and collaborative care models between pediatric oral health and primary care providers: a scoping review of the literature
Tylor L Gauger, Lisa A Prosser, Margherita Fontana, et al.
Journal of Public Health Management and Practice : JPHMP
|
May 29, 2019
Priorities for Investing in Community Health Improvement: A Comparison of Decision Makers in Public Health, Nonprofit Hospitals, and Community Nonprofits
Michael D Rozier, Simone R Singh, Peter D Jacobson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 16, 2004
Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis
Lisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
BMC Medical Informatics and Decision Making
|
May 13, 2010
Use of outcomes to evaluate surveillance systems for bioterrorist attacks
Kerry A McBrien, Ken P Kleinman, Allyson M Abrams, et al.
Plos One
|
June 23, 2016
Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right
Michael J Harvey, Lisa A Prosser, Mark L Messonnier, et al.
Applied Health Economics and Health Policy
|
January 22, 2024
Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA
Tran T Doan, David W Hutton, Davene R Wright, et al.
Page
of 17
Search research articles
Search
Showing results (41-50 of 168) with videos related to
Sort By:
Page
of 17
Pharmacoeconomics
|
September 25, 2007
Valuing children's health: a comparison of cost-utility analyses for adult and paediatric health interventions in the US
Joseph A Ladapo, Peter J Neumann, Ron Keren, et al.
Archives of Pediatrics & Adolescent Medicine
|
September 3, 2008
Parental tolerance of false-positive newborn screening results
Lisa A Prosser, Joseph A Ladapo, Donna Rusinak, et al.
Ambulatory Pediatrics : the Official Journal of the Ambulatory Pediatric Association
|
January 31, 2006
Predictors of hospital charges for children admitted with asthma
Ruchi S Gupta, Meenakshi Bewtra, Lisa A Prosser, et al.
Pharmacoeconomics
|
March 21, 2013
Using a discrete choice experiment to elicit time trade-off and willingness-to-pay amounts for influenza health-related quality of life at different ages
Lisa A Prosser, Katherine Payne, Donna Rusinak, et al.
Journal of Public Health Dentistry
|
April 1, 2018
Integrative and collaborative care models between pediatric oral health and primary care providers: a scoping review of the literature
Tylor L Gauger, Lisa A Prosser, Margherita Fontana, et al.
Journal of Public Health Management and Practice : JPHMP
|
May 29, 2019
Priorities for Investing in Community Health Improvement: A Comparison of Decision Makers in Public Health, Nonprofit Hospitals, and Community Nonprofits
Michael D Rozier, Simone R Singh, Peter D Jacobson, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
September 16, 2004
Cost-effectiveness of interferon beta-1a, interferon beta-1b, and glatiramer acetate in newly diagnosed non-primary progressive multiple sclerosis
Lisa A Prosser, Karen M Kuntz, Amit Bar-Or, et al.
BMC Medical Informatics and Decision Making
|
May 13, 2010
Use of outcomes to evaluate surveillance systems for bioterrorist attacks
Kerry A McBrien, Ken P Kleinman, Allyson M Abrams, et al.
Plos One
|
June 23, 2016
Hitting the Optimal Vaccination Percentage and the Risks of Error: Why to Miss Right
Michael J Harvey, Lisa A Prosser, Mark L Messonnier, et al.
Applied Health Economics and Health Policy
|
January 22, 2024
Estimating Transition Probabilities for Modeling Major Depression in Adolescents by Sex and Race or Ethnicity Combinations in the USA
Tran T Doan, David W Hutton, Davene R Wright, et al.
Page
of 17